{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"deadweight_loss_reduction__pharmacology_toxicology","trajectory_id":"R","attempt_index":0,"archetype_slug":"deadweight_loss_reduction","domain_slug":"pharmacology_toxicology","decision":"CANDIDATE","problem_id":"full_rereview_of_non_risk_increasing_toxicology_protocol_amendments","causal_lever_id":"risk_tiered_minor_amendment_review","proposal":{"problem":"HYPOTHESIS: Animal toxicology programs may subject minor, non-risk-increasing protocol amendments to the same serial review path as new compounds, dose escalations, or materially different procedures. The resulting queue can idle study capacity, delay dose-response evidence, and prolong animal housing without adding commensurate protection.","actors_substrate":["toxicology investigators and laboratory staff","animal-care and biosafety reviewers","research institutions and sponsors","animals enrolled or held for studies","downstream users of safety evidence"],"observable_state":"Among amendments prospectively classified as minor, measure submission-to-decision time, reviewer touches, duplicate information requests, study-days delayed, animal holding-days, deviations, adverse welfare events, and later reclassification to full review.","consequence":"Potentially beneficial and time-sensitive study adjustments are delayed; staff and facilities remain idle or repeat work; animals may remain on study longer, while genuinely hazardous changes compete for the same review attention.","affected_objective":"Reduce avoidable amendment delay and resource loss while maintaining animal-welfare, biosafety, scientific-validity, and legal protections.","structural_mapping":[{"archetype_element":"value-blocking wedge","domain_realization":"INFERENCE: A uniform full-review pathway may impose procedural delay on amendments that do not increase biological or welfare risk.","claim_kind":"INFERENCE"},{"archetype_element":"blocked beneficial activity","domain_realization":"HYPOTHESIS: Timely low-risk corrections, sampling adjustments, or schedule changes that preserve study validity and welfare.","claim_kind":"HYPOTHESIS"},{"archetype_element":"protected purpose","domain_realization":"Substantive scrutiny of animal welfare, dose escalation, hazardous-agent handling, scientific validity, and authorization.","claim_kind":"INFERENCE"},{"archetype_element":"specific redesign","domain_realization":"A documented risk screen routes predefined non-risk-increasing amendments to expedited review and all uncertain or higher-risk changes to full review.","claim_kind":"HYPOTHESIS"},{"archetype_element":"bounded learning loop","domain_realization":"A small, expiring pilot compares expedited eligible cases with the ordinary pathway and automatically reverts on safety triggers.","claim_kind":"HYPOTHESIS"}],"component_map":[{"component":"Distortion Map","status":"direct","domain_realization":"Map amendment classes, handoffs, duplicate requests, queues, and delay attributable to procedure rather than substantive review."},{"component":"Protected Constraint Safeguard","status":"direct","domain_realization":"Exclude dose escalation, new hazards, increased invasiveness, uncertain welfare effects, and legally mandated full review."},{"component":"Surplus Estimate","status":"adapted","domain_realization":"Estimate study-days, facility time, labor, animal holding-days, and decision value recovered; do not monetize animal harm away."},{"component":"Affected-Party Incidence Map","status":"direct","domain_realization":"Record effects on investigators, reviewers, institutions, animals, sponsors, and downstream evidence users."},{"component":"Redesign Lever","status":"direct","domain_realization":"Use predefined risk tiers, single intake, parallel checks, and an expedited minor-amendment lane."},{"component":"Distributional Review","status":"direct","domain_realization":"Check whether speed benefits sponsors while shifting workload, uncertainty, or welfare risk to reviewers, technicians, or animals."},{"component":"Behavioral Response Model","status":"adapted","domain_realization":"Anticipate underclassification, amendment splitting, increased submissions, reviewer overrides, and queue displacement."},{"component":"Implementation Boundary","status":"direct","domain_realization":"Limit the pilot to one facility, predefined amendment types, trained reviewers, and a fixed case count and duration."},{"component":"Monitoring and Rebound Check","status":"direct","domain_realization":"Track delay, overrides, deviations, welfare events, repeat amendments, reviewer burden, and migration of delay elsewhere."},{"component":"Rollback or Adjustment Rule","status":"direct","domain_realization":"Suspend expedited routing after a serious attributable event or threshold breach; restore full review and audit affected cases."},{"component":"Cost–Benefit Assessment Frame","status":"adapted","domain_realization":"Compare recovered time and capacity with transition cost and non-substitutable safety and welfare outcomes."},{"component":"Price-Wedge Diagnostic","status":"incompatible","domain_realization":"Rule out pricing: the hypothesized wedge is risk-insensitive review, not an administered price."},{"component":"Friction Source Breakdown","status":"direct","domain_realization":"Separate required scientific judgment from serial routing, duplication, unclear ownership, and open-ended waiting."},{"component":"Compensating Adjustment Plan","status":"adapted","domain_realization":"Provide reviewer training, override authority, audit time, and workload protection rather than financial compensation."},{"component":"Legitimacy and Authority Review","status":"direct","domain_realization":"Confirm which designated bodies may classify amendments and which reviews cannot be delegated or abbreviated."},{"component":"Sensitivity Analysis","status":"direct","domain_realization":"Vary eligible-case prevalence, time saved, misclassification rate, and severity weighting."},{"component":"Pilot or Sunset Path","status":"direct","domain_realization":"Expire the expedited lane unless predefined efficiency and protection criteria support renewal."}],"mechanism_dispositions":[{"slug":"congestion_or_capacity_pricing_adjustment","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"Reviewer access should not be allocated by willingness to pay; safety priority is not a price problem.","counterfactual_removal":"No change to the causal chain."},{"slug":"cost_benefit_assessment_protocol","disposition":"selected_supporting","contribution_type":"TEST_DESIGN","adaptation_or_rejection":"Use a harm-constrained comparison with explicit uncertainty and incidence.","counterfactual_removal":"The pilot could still operate, but its efficiency claim and tradeoffs would be less reviewable."},{"slug":"distortion_reduction_review","disposition":"selected_load_bearing","contribution_type":"CORE_CAUSAL","adaptation_or_rejection":"Audit the pathway and separate procedural drag from substantive protection before redesign.","counterfactual_removal":"There would be no defensible evidence that an avoidable wedge, rather than necessary scrutiny, causes delay."},{"slug":"impact_assessment_table","disposition":"selected_supporting","contribution_type":"SAFETY_GUARDRAIL","adaptation_or_rejection":"Include animals and frontline staff as affected parties, with uncertainty visible.","counterfactual_removal":"Aggregate time savings could conceal concentrated welfare or workload harms."},{"slug":"matching_improvement_program","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"The hypothesized failure is uniform review intensity, not inability to pair willing parties.","counterfactual_removal":"No change to the causal chain."},{"slug":"permit_or_approval_streamlining","disposition":"selected_load_bearing","contribution_type":"CORE_CAUSAL","adaptation_or_rejection":"Translate to risk-tiered protocol-amendment review while ring-fencing substantive checks.","counterfactual_removal":"The diagnosed procedural wedge would not be altered."},{"slug":"price_control_redesign","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"No cap, floor, subsidy, or compensation-dependent price control is posited.","counterfactual_removal":"No change to the causal chain."},{"slug":"quota_or_allocation_rule_review","disposition":"considered_rejected","contribution_type":"NONE","adaptation_or_rejection":"Reviewer scarcity may affect queues, but the proposed lever changes review depth rather than allocating a fixed quota.","counterfactual_removal":"No material change unless audit evidence instead identifies allocation as binding."},{"slug":"regulatory_simplification_pilot","disposition":"selected_load_bearing","contribution_type":"SAFETY_GUARDRAIL","adaptation_or_rejection":"Wall off eligible amendments, instrument protected outcomes, and require expiry.","counterfactual_removal":"Launching an unvalidated lighter pathway would fail the reversibility and safety gate."},{"slug":"sunset_clause_review","disposition":"selected_supporting","contribution_type":"TEST_DESIGN","adaptation_or_rejection":"Apply sunset to the pilot pathway, not automatically to the underlying welfare rules.","counterfactual_removal":"The experiment could persist by inertia, weakening rollback discipline."},{"slug":"tariff_fee_or_toll_redesign","disposition":"incompatible","contribution_type":"NONE","adaptation_or_rejection":"No authority-imposed charge is the hypothesized barrier.","counterfactual_removal":"No change to the causal chain."}],"causal_chain":["Uniform full review treats low- and high-risk amendments alike.","Minor cases consume serial review steps and queue behind substantively risky cases.","Risk-tiered intake diverts only predefined non-risk-increasing cases to expedited review.","Reviewer override and full-review exclusions preserve scrutiny where uncertainty or hazard is material.","Reduced procedural waiting releases study, staff, facility, and animal-holding time.","Monitoring tests whether gains occur without increased welfare, biosafety, validity, or compliance failures."],"baseline":"All amendments enter the ordinary full-review queue, with case-by-case escalation but no predefined expedited lane.","nearest_rival":"Add reviewer capacity or a submission portal while retaining full review for every amendment; this may shorten queues but does not remove unnecessary review intensity.","authority_safety":{"affected_parties":["animals used or held in studies","laboratory and animal-care staff","investigators and sponsors","reviewers and responsible institutions","downstream users of toxicology evidence"],"decision_authority":"The institution's formally designated animal-use, biosafety, scientific, and compliance authorities retain approval, classification, override, and suspension powers.","authorized_first_step":"Run a prospective, nonbinding audit, then—only with those authorities' approval—pilot expedited review for a small predefined set of non-risk-increasing amendments at one facility.","excluded_actions":["automatic approval without accountable review","expediting dose escalation, new hazardous agents, increased invasiveness, or uncertain welfare effects","waiving legally required review","using aggregate time savings to override an adverse welfare signal"],"halt_rollback":"Immediately suspend expedited routing after a serious plausibly attributable welfare or biosafety event, unauthorized eligibility expansion, or a prespecified excess in deviations or overrides; return pending cases to full review and audit completed cases."}},"negative_tests":{"strongest_counterevidence":"An audit may show that most elapsed time is necessary scientific consultation, that minor amendments are decided promptly already, or that apparently minor changes frequently alter exposure, welfare, or validity.","analogy_break":"Unlike ordinary exchange, toxicology review protects nonconsenting animals and downstream populations against asymmetric, sometimes irreversible harm; blocked activity is not presumptively beneficial, and welfare cannot be reduced to transferable surplus.","failure_condition":"The approach fails if risk tiers cannot be specified reliably, reviewers cannot override them promptly, or expedited cases generate material safety, welfare, validity, or compliance degradation.","problem_falsifier":"The problem is falsified if pathway data show negligible avoidable delay for non-risk-increasing amendments, no idle or holding burden attributable to review, or equivalent substantive-risk distributions across proposed tiers.","intervention_falsifier":"The intervention is falsified if the bounded pilot produces no meaningful cycle-time or burden reduction versus comparable baseline cases, or breaches prespecified noninferiority limits for deviations, overrides, welfare, biosafety, validity, or compliance.","risks":["strategic labeling of substantive changes as minor","rare harms missed by a small pilot","delay displaced to intake or audit","reviewer workload intensified rather than reduced","selection of unusually simple cases exaggerates benefit","institutional authority or legal requirements may forbid abbreviated review"]},"null_rationale":null,"classification":{"candidate_kind":"DOMAIN_TRANSFER","prior_art_status":"UNSEARCHED","evidence_maturity":"HYPOTHESIS"},"revision_change_log":{"revision_kind":"ORIGINAL","prior_problem_id":null,"prior_causal_lever_id":null,"problem_changed":false,"causal_lever_changed":false,"conceptual_changes":[],"operational_changes":[],"repairs_addressed":[]},"confidence":0.78,"generator_notes":"Closed-book structural inference. The existence, frequency, and magnitude of the proposed review wedge are unverified; the candidate depends on prospective pathway data and authorization."}